Skip to main content
. Author manuscript; available in PMC: 2016 Sep 28.
Published in final edited form as: Cancer Lett. 2015 Jun 25;366(1):44–51. doi: 10.1016/j.canlet.2015.05.034

Fig. 6.

Fig. 6

AKT expression and activity are highest in U937 cells and not inhibited by YM155 treatment. (a) Western Blot analysis of AKT activity (pAKT-Ser473) and total AKT protein in cells treated with YM155 for 24 hours. This representative Blot is selected from three independent experiments. (b) AKT transcript expression in HL60 and U937 cells treated with YM155 for 8 hours. Transcript levels are relative to those measured in HL60 control (untreated) and represent the mean ± SD of two independent experiments.